Crystal Unzueta, MD

Offices

2 locations · Stanford Health Care · Peninsula Healthcare Connection Inc

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Unzueta’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence A142631 · Current

Licensed to practise in California · since 2016 · expires 2028-01-31 · University of Illinois College of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024

See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Stanford Health Care

Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	5.31 (4.24 to 6.37) · 8,661 cases	Worse	Jul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	14.1 (12.7 to 15.7) · 2,191 cases	Worse	Jan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths	4.08 (1.95 to 6.21) · 5,296 cases	Better	Jul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.317	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.446	Better	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	0.241	Better	Oct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.7 (0.6 to 0.9) · 3,348 cases	Better	Jan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.06 (0.45 to 1.67) · 5,374 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.86 (0.72 to 1)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	166.09 (137.88 to 194.3) · 470 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	1.1 · 192 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	6.4 · 146 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	9.7 · 253 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	6.3 · 880 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	10.3 · 935 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	8.7 · 501 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.1 · 7,730 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.13 (0 to 0.27) · 20,799 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.28 (0.14 to 0.43) · 23,182 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	0.94 (0.2 to 1.68) · 5,694 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.36 (1.54 to 3.19) · 7,846 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	5.2 (3.76 to 6.64) · 5,603 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.38 (0.23 to 2.53) · 2,211 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.52 (0.21 to 0.83) · 19,915 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	3.6 · 416 cases	None	Apr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.869	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.857	No different	Oct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections	0.368	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	16.2 · 247 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	20.5 · 1,021 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	47.8 · 258 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-1.6 · 990 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	20.8 · 976 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	16.5 · 959 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	5.2 (4.4 to 6.2) · 2,191 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	5.1 · 425 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	9.6 · 158 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	19.6 · 183 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	12.7 (10.4 to 15.4) · 4,578 cases	No different	Jan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Sort by

Patient survey stars by topic at Stanford Health Care

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	2
Recommend hospital	5

Sort by

Share of patients giving the best answer at Stanford Health Care

Room was "always" clean	75%
Nurses "always" communicated well	82%
Doctors "always" communicated well	81%
Staff "always" explained	63%
Yes, staff "did" give patients this information	89%
Yes, staff "did" give patients information about help after discharge	89%
Doctors "always" explained things so they could understand	76%
Doctors "always" listened carefully	80%
Doctors "always" treated them with courtesy and respect	87%
Patients who gave a rating of "9" or "10" (high)	79%
Staff "always" explained new medications	76%
Nurses "always" explained things so they could understand	77%
Nurses "always" listened carefully	79%
Nurses "always" treated them with courtesy and respect	88%
"Always" quiet at night	53%
"YES", patients would definitely recommend the hospital	83%
Staff "always" explained possible side effects	50%
Yes, staff "did" give patients information about possible symptoms	90%

Original Medicare doctor bills

$14,633

Medicare paid this office $14,633 for 132 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Return visit (30+ min)	47	$4,269	$66
Return visit (30+ min)	47	$4,101	$59
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	49	$3,172	$65
Short return visit (20+ min)	17	$1,072	$56
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	12	$699	$58

Who their Medicare patients are

132 Original Medicare patients in 2024. Average age 73 · Under 65 11% · 85 and older 8% · Women 67% · Also on Medicaid 27% · Health risk score 1.30. Above the middle of the specialty; the typical family practice clinician is at 1.13.

Conditions among them: High blood pressure 70% · Diabetes 29% · Coronary heart disease 23% · Depression 22% · Chronic kidney disease 20% · Cancer 15% · Atrial fibrillation 15% · Heart failure 14% · COPD 9%.

The office billed $120,600, Medicare allowed $20,532 and paid $14,633; for 233 services of 10 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	132	233	73	1.30	$120,600	$14,633
2023	122	226	73	1.34	$86,710	$12,629
2022	46	50	71	1.25	$17,526	$2,994

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 4 services

Sort by

Original Medicare services billed in 2023

Return visit (30+ min)	74	$6,668	$57
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	48	$3,077	$64
Long return visit (40+ min)	15	$923	$62
Short return visit (20+ min)	17	$879	$46

2022: 1 service

Sort by

Original Medicare services billed in 2022

Return visit (30+ min)	20	$1,128	$54

Medicaid work

$3,644 in 2023

Medicaid paid $3,644 for 35 billed services this clinician did in 2023, up to 18 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Sort by

Largest Medicaid services in 2023

Clinic visit/encounter, all-inclusive	35	$3,644

Sort by

Medicaid work by year

2023	35	1	18	$3,644
2022	2,241	8	108	$165,022
2021	17,928	47	322	$635,411
2020	24,418	36	403	$822,310
2019	20,182	35	325	$508,757

See the largest Medicaid services in earlier years

2022

Sort by

Largest Medicaid services in 2022

Clinic visit/encounter, all-inclusive	736	$146,909
Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose	156	$10,157
Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; booster dose	42	$2,814
Short return visit (20+ min)	1,092	$1,735
Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; booster dose	26	$1,675
Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose	17	$1,139
Return visit (30+ min)	126	$574
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)	46	$19

2021

Sort by

Largest Medicaid services in 2021

Clinic visit/encounter, all-inclusive	4,170	$594,681
Short return visit (20+ min)	2,398	$9,720
Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; first dose	141	$6,529
Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; second dose	127	$6,515
Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; second dose	125	$4,497
Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique	861	$3,330
Short return visit	996	$2,892
Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; first dose	106	$2,695
Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose	14	$871
OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES	134	$704
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion	1,583	$624
Return visit (30+ min)	149	$600

2020

Sort by

Largest Medicaid services in 2020

Clinic visit/encounter, all-inclusive	5,791	$809,532
Short return visit (20+ min)	3,915	$7,542
Short return visit	801	$2,384
Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use	81	$717
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion	2,814	$615
Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use	252	$405
OFFICE/OUTPATIENT VISIT NEW	160	$369
BODY MASS INDEX DOCD	3,208	$232
Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use	23	$164
Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique	45	$103
Handling and/or conveyance of specimen for transfer from physician office to laboratory	787	$62
URINE PREGNANCY TEST	67	$45

2019

Sort by

Largest Medicaid services in 2019

Clinic visit/encounter, all-inclusive	3,513	$481,206
Short return visit (20+ min)	3,562	$15,810
Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years)	271	$2,932
Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years)	167	$2,367
Screening test, pure tone, air only	557	$1,274
Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years	46	$1,259
Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years)	182	$1,095
Developmental screening	13	$604
Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use	379	$387
Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use	117	$353
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)	254	$203
Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD)	1,246	$197

Drugs they prescribed that Part D paid

$95,248

Pharmacies billed $95,248 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 1% of their Part D prescriptions (13 of 932) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.

830 generic and fewer than 11 brand-name prescriptions · $95,248 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Ozempic	21	$23,802	$1,133
Gabapentin	48	$1,224	$25
Omeprazole	30	$1,064	$35
Atorvastatin	81	$1,055	$13
Rosuvastatin	22	$954	$43

See all 19 drugs

Sort by

Every Part D drug this clinician prescribed

Ozempic	21	$23,802	$1,133
Gabapentin	48	$1,224	$25
Omeprazole	30	$1,064	$35
Atorvastatin	81	$1,055	$13
Rosuvastatin	22	$954	$43
Levothyroxine	41	$416	$10
Simvastatin	12	$361	$30
Venlafaxine Hcl Er	12	$304	$25
Losartan	26	$280	$11
Pantoprazole	14	$229	$16
Tamsulosin	14	$219	$16
Lisinopril	30	$208	$7
Amlodipine Besylate	41	$154	$4
Allopurinol	17	$153	$9
Metformin	20	$130	$7
Trazodone	12	$93	$8
Hydrocodone-Acetaminophen	13	$87	$7
Hydrochlorothiazide	23	$46	$2
Lorazepam	11	$44	$4

Year by year

Sort by

Part D prescribing by year

2024	932	118	1% (13)	None	$95,248
2023	813	138	None	None	$93,144
2022	517	131	None	None	$46,151
2021	849	117	None	13%	$75,763
2020	1,191	93	None	18%	$135,401
2019	1,092	104	None	18%	$97,527
2018	680	74	2% (11)	16%	$54,037
2017	422	52	None	10%	$20,824
2016	261	35	0% (0)	None	$6,526
2015	100	None	0% (0)	39%	$4,871

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 19 drugs

Sort by

Part D drugs prescribed in 2023

Ozempic	15	$16,023	$1,068
Eliquis	11	$15,079	$1,371
Atorvastatin	58	$969	$17
Amlodipine Besylate	48	$908	$19
Omeprazole	29	$800	$28
Losartan	29	$725	$25
Venlafaxine Hcl Er	11	$700	$64
Rosuvastatin	23	$671	$29
Simvastatin	15	$669	$45
Gabapentin	30	$591	$20
Tamsulosin	17	$507	$30
Levothyroxine	35	$472	$13
Hydroxyzine	11	$428	$39
Metformin	27	$356	$13
Fluticasone Propionate	14	$353	$25
Lisinopril	16	$256	$16
Hydrochlorothiazide	29	$223	$8
Prednisone	22	$116	$5
Lorazepam	14	$44	$3

2022: 12 drugs

Sort by

Part D drugs prescribed in 2022

Atorvastatin	30	$555	$18
Diclofenac	11	$487	$44
Amlodipine Besylate	45	$430	$10
Metformin	18	$422	$23
Gabapentin	19	$367	$19
Losartan	26	$335	$13
Levothyroxine	15	$250	$17
Escitalopram	11	$238	$22
Lisinopril	22	$234	$11
Tamsulosin	11	$215	$20
Omeprazole	14	$141	$10
Hydrochlorothiazide	21	$109	$5

2021: 22 drugs

Sort by

Part D drugs prescribed in 2021

Januvia	20	$21,780	$1,089
Atorvastatin	71	$925	$13
Levothyroxine	20	$700	$35
Albuterol Sulfate Hfa	13	$547	$42
Diclofenac	12	$347	$29
Metformin	42	$322	$8
Gabapentin	24	$305	$13
Lisinopril	45	$291	$6
Losartan	24	$288	$12
Glipizide	27	$244	$9
Pioglitazone	18	$223	$12
Clotrimazole	13	$220	$17
Famotidine	25	$192	$8
Fluticasone Propionate	13	$155	$12
Amlodipine Besylate	39	$151	$4
Hydrochlorothiazide	22	$108	$5
Alendronate	19	$98	$5
Metoprolol	14	$92	$7
Ibuprofen	15	$88	$6
Simvastatin	15	$49	$3
Benazepril	12	$49	$4
Furosemide	12	$39	$3

2020: 28 drugs

Sort by

Part D drugs prescribed in 2020

Januvia	35	$24,340	$695
Eliquis	18	$14,257	$792
Novolog Mix 70-30	12	$10,353	$863
Basaglar Kwikpen U-100	14	$4,506	$322
Atorvastatin	100	$1,678	$17
Albuterol Sulfate Hfa	21	$1,080	$51
Chlorthalidone	20	$1,079	$54
Levothyroxine	26	$824	$32
Gabapentin	43	$669	$16
Metformin	79	$520	$7
Diclofenac	16	$479	$30
Fluticasone Propionate	19	$393	$21
Lisinopril	65	$358	$6
Amlodipine Besylate	44	$280	$6
Meclizine	14	$258	$18
Glipizide	25	$237	$9
Losartan	24	$221	$9
Clotrimazole	13	$196	$15
Benazepril	23	$191	$8
Famotidine	23	$163	$7
Pioglitazone	14	$152	$11
Hydrochlorothiazide	34	$142	$4
Hydrocortisone	11	$102	$9
Omeprazole	16	$97	$6
Simvastatin	20	$73	$4
Meloxicam	20	$57	$3
Clonazepam	12	$43	$4
Ibuprofen	11	$34	$3

2019: 26 drugs

Sort by

Part D drugs prescribed in 2019

Januvia	28	$16,705	$597
Lantus	19	$10,274	$541
Atorvastatin	72	$1,431	$20
Chlorthalidone	21	$1,114	$53
Levothyroxine	35	$904	$26
Ventolin Hfa	16	$891	$56
Nifedipine Er	12	$814	$68
Gabapentin	32	$686	$21
Metformin	72	$523	$7
Amlodipine Besylate	46	$517	$11
Clopidogrel	14	$399	$28
Tamsulosin	22	$387	$18
Fluticasone Propionate	28	$385	$14
Nitroglycerin	11	$277	$25
Lisinopril	36	$259	$7
Glipizide	30	$239	$8
Clotrimazole	15	$193	$13
Simvastatin	35	$184	$5
Benazepril	21	$174	$8
Losartan	18	$114	$6
Omeprazole	11	$111	$10
Ranitidine	23	$104	$5
Hydrochlorothiazide	24	$101	$4
Metoprolol	13	$100	$8
Ibu	13	$83	$6
Alendronate	13	$61	$5

2018: 15 drugs

Sort by

Part D drugs prescribed in 2018

Januvia	12	$8,331	$694
Chlorthalidone	16	$755	$47
Atorvastatin	40	$632	$16
Metformin	57	$408	$7
Amlodipine Besylate	40	$342	$9
Clopidogrel	11	$318	$29
Lisinopril	30	$250	$8
Levothyroxine	13	$246	$19
Tamsulosin	14	$201	$14
Glipizide	18	$180	$10
Fluticasone Propionate	19	$161	$8
Ranitidine	13	$115	$9
Simvastatin	18	$86	$5
Hydrochlorothiazide	17	$57	$3
Warfarin	11	$47	$4

2017: 10 drugs

Sort by

Part D drugs prescribed in 2017

Atorvastatin	34	$388	$11
Metformin	42	$286	$7
Glipizide	16	$166	$10
Ranitidine	18	$116	$6
Fluticasone Propionate	12	$114	$9
Alendronate	17	$108	$6
Omeprazole	18	$73	$4
Hydrochlorothiazide	18	$67	$4
Simvastatin	14	$56	$4
Lisinopril	16	$40	$3

2016: 6 drugs

Sort by

Part D drugs prescribed in 2016

Metformin	28	$131	$5
Omeprazole	19	$100	$5
Glipizide	16	$94	$6
Alendronate	13	$44	$3
Hydrochlorothiazide	13	$31	$2
Furosemide	13	$31	$2

2015: 1 drug

Sort by

Part D drugs prescribed in 2015

Proair Hfa	14	$1,008	$72

Money from drug and device companies

$20 in 2019

A payment is not proof that care is biased.

Sort by

Payments by company

Merck Sharp & Dohme	Nexplanon	$20	1 payment Meals for Nexplanon · 2019-06-26 · $20

See the published payment

Sort by

Every published payment

Merck Sharp & Dohme	Meals · 2019-06-26	Nexplanon	$20

Professional record

NPI: 1538574470
Licence: CA A142631California A142631: Current · expires 2028-01-31
Trained: University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb), 2014
Group: Stanford Health Care · Peninsula Healthcare Connection Inc
Video visits: Lists video visits
Gender: Female

More record details

Sole proprietor: No
Taxonomy: Family medicine (207Q00000X)
Mailing address: 300 Pasteur Dr, Stanford, CA, 94305
NPI first listed: 2014-06-30
NPI last updated: 2024-04-17
NPI record certified: 2024-04-17

This is when the NPI record was last certified, not a medical board exam.

This office lists an electronic records connection.